Home › Markets › Health Care › LABT

Lakewood-Amedex Biotherapeutics Inc. (LABT)

LABT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.6939
-5.08% on the day
Market cap
$1.6M
Nano cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerLABT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0002079272
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials

New registrant: no annual report filed under this company yet.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
S-12026-09-18
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-14
Latest current report
CURRENT REPORT
8-K2026-09-29
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-08-10

Source: SEC EDGAR submissions feed, 44 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ARTLArtelo Biosciences Inc.$2.98-4.18%$1.6M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.3502-8.61%$1.5M
OGENOragenics Inc.$0.4469-0.16%$2.0M
GNPXGenprex Inc.$2.51-6.69%$2.1M
SILOSilo Pharma Inc.$1.22-18.12%$2.1M
PPBTPurple Biotech Ltd.$1.36-1.45%$2.2M
SPRCSciSparc Ltd.$3.94-3.43%$2.3M
ELABPMGC Holdings Inc.$2.96-2.95%$2.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier